Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuya Sumi

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Plos One|January 10, 2013
Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm-associated JAK2 V617F mutantMegumi Funakoshi-Tago, Kazuya Sumi, Tadashi Kasahara, et al.
FEBS Letters|May 12, 2011
Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cellsKazuya Sumi, Kenji Tago, Tadashi Kasahara, et al.
Cellular Signalling|July 11, 2013
Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugsFumihito Ueda, Kazuya Sumi, Kenji Tago, et al.
ERJ Open Research|April 3, 2023
Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β<sub>2</sub>-agonist therapy in patients with asthma: REACH study designAkio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, et al.
Advances in Therapy|May 20, 2025
Reality of Patient-Reported Symptoms in 200 Patients with Eosinophilic Granulomatosis with Polyangiitis: A Cross-Sectional Survey (The KUNPU Study)Koichi Amano, Keita Ono, Kazuya Sumi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 4, 2021
Once-daily, single-inhaler indacaterol/mometasone versus twice-daily salmeterol/fluticasone in Asian patients with inadequately controlled asthma: <i>post hoc</i> pooled analysis from PALLADIUM and IRIDIUM studiesYasuhiro Gon, Tsuyoshi Ishii, David Lawrence, et al.
Pulmonary Pharmacology & Therapeutics|September 20, 2020
Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillanceKoichiro Asano, Kazuya Sumi, Hajime Yoshisue, et al.
International Journal of Molecular Sciences|January 21, 2022
Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 CellsKazuya Sumi, Kenji Tago, Yosuke Nakazawa, et al.
European Journal of Pharmacology|December 26, 2021
A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cellsKazuya Sumi, Kenji Tago, Yosuke Nakazawa, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|June 18, 2023
Long-term efficacy of antireflux mucosectomy in patients with refractory gastroesophageal reflux diseaseKazuya Sumi, Haruhiro Inoue, Ryohei Ando, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Plos One|January 10, 2013
Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm-associated JAK2 V617F mutantMegumi Funakoshi-Tago, Kazuya Sumi, Tadashi Kasahara, et al.
FEBS Letters|May 12, 2011
Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cellsKazuya Sumi, Kenji Tago, Tadashi Kasahara, et al.
Cellular Signalling|July 11, 2013
Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugsFumihito Ueda, Kazuya Sumi, Kenji Tago, et al.
ERJ Open Research|April 3, 2023
Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β<sub>2</sub>-agonist therapy in patients with asthma: REACH study designAkio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, et al.
Advances in Therapy|May 20, 2025
Reality of Patient-Reported Symptoms in 200 Patients with Eosinophilic Granulomatosis with Polyangiitis: A Cross-Sectional Survey (The KUNPU Study)Koichi Amano, Keita Ono, Kazuya Sumi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 4, 2021
Once-daily, single-inhaler indacaterol/mometasone versus twice-daily salmeterol/fluticasone in Asian patients with inadequately controlled asthma: <i>post hoc</i> pooled analysis from PALLADIUM and IRIDIUM studiesYasuhiro Gon, Tsuyoshi Ishii, David Lawrence, et al.
Pulmonary Pharmacology & Therapeutics|September 20, 2020
Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillanceKoichiro Asano, Kazuya Sumi, Hajime Yoshisue, et al.
International Journal of Molecular Sciences|January 21, 2022
Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 CellsKazuya Sumi, Kenji Tago, Yosuke Nakazawa, et al.
European Journal of Pharmacology|December 26, 2021
A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cellsKazuya Sumi, Kenji Tago, Yosuke Nakazawa, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|June 18, 2023
Long-term efficacy of antireflux mucosectomy in patients with refractory gastroesophageal reflux diseaseKazuya Sumi, Haruhiro Inoue, Ryohei Ando, et al.
Pageof 5